Nanologica AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005454873
SEK
0.51
-0.03 (-5.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
21.46
5.21
2.84
2.33
10.75
6.71
0.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
21.46
5.21
2.84
2.33
10.75
6.71
0.61
Raw Material Cost
31.35
20.94
12.93
13.07
22.52
19.25
17.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
14.76
7.05
5.44
6.18
5.87
5.58
4.88
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.46
1.07
0.97
1.55
1.05
2.30
1.55
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-1.62
-0.81
-0.64
-0.77
-0.69
-0.79
-0.64
Total Expenditure (Excl Depreciation)
31.35
20.94
12.93
13.07
22.52
19.25
17.65
Operating Profit (PBDIT) excl Other Income
-9.9
-15.700000000000001
-10.1
-10.700000000000001
-11.799999999999999
-12.5
-17
Other Income
76.54
0.07
0.06
-0.03
0.25
0.20
-0.18
Operating Profit (PBDIT)
72.25
-13.16
-7.98
-7.58
-5.47
-8.08
-16.99
Interest
1.46
1.07
0.97
1.55
1.05
2.30
1.55
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-9.90
-15.73
-10.09
-10.74
-11.77
-12.53
-17.04
Depreciation
5.60
2.50
2.04
3.18
3.64
3.65
5.17
Profit Before Tax
65.19
-16.73
-11.00
-12.31
-10.17
-14.03
-23.70
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
65.19
-16.73
-11.00
-12.31
-10.17
-14.03
-23.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
65.19
-16.73
-11.00
-12.31
-10.17
-14.03
-23.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
65.19
-16.73
-11.00
-12.31
-10.17
-14.03
-23.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.1
0.1
Reserves
97.50
22.64
40.45
51.59
63.94
74.11
-8.84
Earnings per share (EPS)
0.72
-0.19
-0.12
-0.14
-0.11
-0.19
-0.53
Diluted Earnings per share
0.72
-0.19
-0.12
-0.14
-0.11
-0.19
-0.53
Operating Profit Margin (Excl OI)
-46.13%
-302.23%
-354.77%
-459.87%
-87.1%
-177.81%
-3596.07%
Gross Profit Margin
329.93%
-273.45%
-314.91%
-391.09%
-60.72%
-154.56%
-3033.55%
PAT Margin
303.81%
-321.48%
-386.84%
-527.28%
-94.61%
-208.98%
-3879.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 313.46% vs 85.71% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 490.42% vs -51.82% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 67.42% vs -65.00% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 36.36% vs 10.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Nanologica AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
21.46
39.36
-17.90
-45.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
21.46
39.36
-17.90
-45.48%
Raw Material Cost
31.35
29.78
1.57
5.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
14.76
10.03
4.73
47.16%
Power Cost
0
0
0.00
Manufacturing Expenses
1.46
1.94
-0.48
-24.74%
Selling and Distribution Expenses
0.00
-24.28
24.28
100.00%
Other Expenses
-1.62
1.23
-2.85
-231.71%
Total Expenditure (Excl Depreciation)
31.35
29.78
1.57
5.27%
Operating Profit (PBDIT) excl Other Income
-9.90
9.58
-19.48
-203.34%
Other Income
76.54
1.47
75.07
5,106.80%
Operating Profit (PBDIT)
72.25
12.10
60.15
497.11%
Interest
1.46
1.94
-0.48
-24.74%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-9.90
9.59
-19.49
-203.23%
Depreciation
5.60
1.04
4.56
438.46%
Profit Before Tax
65.19
9.12
56.07
614.80%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
65.19
9.12
56.07
614.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
65.19
9.12
56.07
614.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
65.19
9.12
56.07
614.80%
Equity Capital
0
0
0.00
Face Value
0.05
0.02
0.00
Reserves
97.50
39.84
57.66
144.73%
Earnings per share (EPS)
0.72
0.11
0.61
554.55%
Diluted Earnings per share
0.72
0.11
0.61
554.55%
Operating Profit Margin (Excl OI)
-46.13%
24.35%
0.00
-70.48%
Gross Profit Margin
329.93%
25.83%
0.00
304.10%
PAT Margin
303.81%
23.18%
0.00
280.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2.15 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 313.46% vs 85.71% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 99.07% vs 116.00% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.52 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 490.42% vs -51.82% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 739.22% vs 39.29% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.43 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 67.42% vs -65.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 24.56% vs 46.23% in Mar 2025

Quarterly - Interest
Interest 0.15 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 36.36% vs 10.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 36.36% vs -21.43% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -46.13%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025